These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts. Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351 [TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Allison J; Georgiou HM; Strasser A; Vaux DL Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3943-7. PubMed ID: 9108084 [TBL] [Abstract][Full Text] [Related]
12. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186 [TBL] [Abstract][Full Text] [Related]
13. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates. Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281 [TBL] [Abstract][Full Text] [Related]
14. Murine heart transgenic Fas ligand expression protects against allograft rejection. Zuraff-Perryman LA; Duke RC; Setser E; Nelson DP; Bellgrau D Transplant Proc; 2002 Dec; 34(8):3396-8. PubMed ID: 12493481 [No Abstract] [Full Text] [Related]
15. Muscling transplants into mice. Wickelgren I Science; 1996 Jul; 273(5271):33. PubMed ID: 8658188 [No Abstract] [Full Text] [Related]
16. Expression of Fas and Fas ligand in renal grafts with acute and chronic rejection in the rat model. Wang J; Nonomura N; Ichimaru N; Azuma H; Hatori M; Kokado Y; Matsumiya K; Miki T; Takahara S; Okuyama A J Interferon Cytokine Res; 1997 Jun; 17(6):369-73. PubMed ID: 9198004 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of locally produced CD95 ligand. Seino K; Kayagaki N; Okumura K; Yagita H Nat Med; 1997 Feb; 3(2):165-70. PubMed ID: 9018234 [TBL] [Abstract][Full Text] [Related]